Explore the latest health technology that is changing the pharma industry, and discover how these innovations could solve key ...

Discover an ongoing study that is using a new biomarker to identify those at highest risk of non-adherence and how much ...

Discover a study that explores the feasibility and benefits of aerobic versus resistance exercise for men undergoing prostate ...

From new industry M&As to insights on how to recruit Gen Z talent, there’s plenty to discover in our latest pharma news round ...

Patients with rheumatoid arthritis and cancer seek clear information on drug safety, cancer risks, and treatment decisions, a ...

Discover a recent report that states that, although GLP-1 medicines are generally well tolerated, there have been cases of ...

Patients with autoimmune skin diseases had improved survival after cancer treatment, suggesting a potential immunologic advantage and prompting further research into autoimmune-cancer interactions.

Rising one place to number one overall, the British drugmaker has overtaken the NHS as the preferred destination for science ...

Stefan Oelrich is elected EFPIA President, as new leadership calls for action to restore Europe’s global leadership in pharma ...

A groundbreaking multinational clinical trial, named RESILIENCE, is underway to test a promising new treatment aimed at ...

A blood test taken in the first trimester could identify women at risk of preeclampsia months before clinical signs emerge, ...

Techniques like intravascular ultrasound (IVUS) and optical coherence tomography (OCT) are increasingly recommended to guide ...